The Serendipitous Story of SGLT2 Inhibitors in Heart Failure
- PMID: 30882236
- DOI: 10.1161/CIRCULATIONAHA.119.040514
The Serendipitous Story of SGLT2 Inhibitors in Heart Failure
Keywords: Editorials; SGLT2 inhibitors; diabetes mellitus; heart failure.
Comment on
-
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus.Circulation. 2019 May 28;139(22):2528-2536. doi: 10.1161/CIRCULATIONAHA.119.040130. Epub 2019 Mar 18. Circulation. 2019. PMID: 30882238 Clinical Trial.
-
Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.Circulation. 2019 May 28;139(22):2516-2527. doi: 10.1161/CIRCULATIONAHA.119.039996. Epub 2019 Mar 18. Circulation. 2019. PMID: 30882239 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical